Suggest a news
Latest news
Distalmotion, a global MedTech company based à Biopôle-Lausanne and focused on expanding access to robotic surgery in outpatient settings, announced…
The drug candidate, intended for the treatment of schizophrenia, is now set to enter Phase II. Addex holds a 20…
The Foundation for Innovation and Technology (FIT) is supporting three life sciences start-ups through Tech Seed loans. Biodelphis Therapeutics is…